BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6279488)

  • 1. Generation of cross-reactive cytotoxic T lymphocytes following immunization of mice with various bluetongue virus types.
    Jeggo MH; Wardley RC
    Immunology; 1982 Apr; 45(4):629-35. PubMed ID: 6279488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of murine cytotoxic T lymphocytes by bluetongue virus following various immunisation procedures.
    Jeggo MH; Wardley RC
    Res Vet Sci; 1982 Sep; 33(2):212-5. PubMed ID: 6293026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The induction of murine cytotoxic T lymphocytes by bluetongue virus.
    Jeggo MH; Wardley RC
    Arch Virol; 1982; 71(3):197-206. PubMed ID: 6285856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cultivation of bluetongue virus-specific ovine T cells and their cross-reactivity with different serotype viruses.
    Takamatsu H; Jeggo MH
    Immunology; 1989 Feb; 66(2):258-63. PubMed ID: 2466772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of ovine cytotoxic T cells in protection against bluetongue virus infection.
    Jeggo MH; Wardley RC; Brownlie J
    Prog Clin Biol Res; 1985; 178():477-87. PubMed ID: 2989889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial inoculation of sheep with two bluetongue virus types.
    Jeggo MH; Wardley RC; Brownlie J; Corteyn AH
    Res Vet Sci; 1986 May; 40(3):386-92. PubMed ID: 3016851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and serological outcome following the simultaneous inoculation of three bluetongue virus types into sheep.
    Jeggo MH; Wardley RC; Taylor WP
    Res Vet Sci; 1984 Nov; 37(3):368-70. PubMed ID: 6097969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cellular immune response of sheep to bluetongue virus.
    Ghalib HW; Cherrington JM; Adkison MA; Osburn BI
    Prog Clin Biol Res; 1985; 178():489-96. PubMed ID: 2989890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bluetongue vaccine: cells and/or antibodies.
    Jeggo MH; Wardley RC
    Vaccine; 1985 Mar; 3(1):57-8. PubMed ID: 2988227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of neutralising antibody in passive immunity to bluetongue infection.
    Jeggo MH; Wardley RC; Taylor WP
    Res Vet Sci; 1984 Jan; 36(1):81-6. PubMed ID: 6324311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plaque neutralization cross reactivity of post infection bovine sera amongst bluetongue virus serotypes.
    Thomas FC
    Prog Clin Biol Res; 1985; 178():511-2. PubMed ID: 2989894
    [No Abstract]   [Full Text] [Related]  

  • 12. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
    Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
    Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
    Feenstra F; Pap JS; van Rijn PA
    Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep.
    Zulu GB; Venter EH
    J S Afr Vet Assoc; 2014 Oct; 85(1):1041. PubMed ID: 25686101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to bluetongue virus define two neutralizing epitopes and a hemagglutinating epitope.
    Mecham JO; Jochim MM
    Viral Immunol; 1990; 3(2):161-70. PubMed ID: 1694430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccine prime and recombinant FPV vaccine boost: an important candidate immunization strategy to control bluetongue virus type 1.
    Li J; Yang T; Xu Q; Sun E; Feng Y; Lv S; Zhang Q; Wang H; Wu D
    Appl Microbiol Biotechnol; 2015 Oct; 99(20):8643-52. PubMed ID: 26048472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and serological response of sheep to serial challenge with different bluetongue virus types.
    Jeggo MH; Gumm ID; Taylor WP
    Res Vet Sci; 1983 Mar; 34(2):205-11. PubMed ID: 6304836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public H-2 specificities are target determinants for alloreactive cytotoxic T lymphocytes.
    Vazquez A; Senik A; Fridman WH; Neauport-Sautes C
    J Immunogenet; 1980 Feb; 7(1):107-22. PubMed ID: 6154748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines.
    Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD
    Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VP2, VP7, and NS1 proteins of bluetongue virus targeted in avian reovirus muNS-Mi microspheres elicit a protective immune response in IFNAR(-/-) mice.
    Marín-López A; Otero-Romero I; de la Poza F; Menaya-Vargas R; Calvo-Pinilla E; Benavente J; Martínez-Costas JM; Ortego J
    Antiviral Res; 2014 Oct; 110():42-51. PubMed ID: 25057758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.